BACKGROUND: Lung cancer is the second most common neoplasm and the leading cause of cancer deaths in the United States. In cancer, weight loss and obesity are associated with reduced survival. However, the effect of obesity or weight loss at presentation on lung cancer survival has not been well studied. MATERIALS AND METHODS: Using an extensive cancer dataset, we identified 76,086 patients diagnosed with lung cancer during the period of 1998-2002, of which 14,751 patients presented with obesity and/or weight loss. We examined the relationship between survival and weight loss or obesity at diagnosis using univariate and multivariate analysis. RESULTS: Median survival time (MST) for all lung cancer patients was 8.7 mo. Patients presenting with weight loss (15.8%) had shorter MST versus those who did not (6.4 versus 9.2 mo, P < 0.001) and patients with weight loss had significantly shortened MST for all stages and histologic subtypes. In contrast, obese patients at presentation (5.4%) had longer MST relative to non-obese patients (13.0 versus 8.6 mo, P < 0.001), which was significant across all stages and histologic subtypes. Multivariate analysis revealed that the absence of weight loss was an independent, positive predictor of improved survival (HR = 0.087, P < 0.001), while the absence of obesity was an independent predictor of worsened survival in lung cancer (HR = 1.16, P < 0.001). CONCLUSIONS: Our results demonstrate an inverse relationship between survival and weight loss at presentation and a potentially protective effect of obesity in lung cancer survival, which could be due to greater physiologic reserves, thereby prolonging life by slowing the progress of cancer cachexia.
BACKGROUND:Lung cancer is the second most common neoplasm and the leading cause of cancer deaths in the United States. In cancer, weight loss and obesity are associated with reduced survival. However, the effect of obesity or weight loss at presentation on lung cancer survival has not been well studied. MATERIALS AND METHODS: Using an extensive cancer dataset, we identified 76,086 patients diagnosed with lung cancer during the period of 1998-2002, of which 14,751 patients presented with obesity and/or weight loss. We examined the relationship between survival and weight loss or obesity at diagnosis using univariate and multivariate analysis. RESULTS: Median survival time (MST) for all lung cancerpatients was 8.7 mo. Patients presenting with weight loss (15.8%) had shorter MST versus those who did not (6.4 versus 9.2 mo, P < 0.001) and patients with weight loss had significantly shortened MST for all stages and histologic subtypes. In contrast, obesepatients at presentation (5.4%) had longer MST relative to non-obesepatients (13.0 versus 8.6 mo, P < 0.001), which was significant across all stages and histologic subtypes. Multivariate analysis revealed that the absence of weight loss was an independent, positive predictor of improved survival (HR = 0.087, P < 0.001), while the absence of obesity was an independent predictor of worsened survival in lung cancer (HR = 1.16, P < 0.001). CONCLUSIONS: Our results demonstrate an inverse relationship between survival and weight loss at presentation and a potentially protective effect of obesity in lung cancer survival, which could be due to greater physiologic reserves, thereby prolonging life by slowing the progress of cancer cachexia.
Authors: W D Dewys; C Begg; P T Lavin; P R Band; J M Bennett; J R Bertino; M H Cohen; H O Douglass; P F Engstrom; E Z Ezdinli; J Horton; G J Johnson; C G Moertel; M M Oken; C Perlia; C Rosenbaum; M N Silverstein; R T Skeel; R W Sponzo; D C Tormey Journal: Am J Med Date: 1980-10 Impact factor: 4.965
Authors: Eduardo A Perez; Leonidas G Koniaris; Sarah E Snell; Juan C Gutierrez; William E Sumner; David J Lee; Nicole C Hodgson; Alan S Livingstone; Dido Franceschi Journal: World J Surg Date: 2007-05 Impact factor: 3.352
Authors: Richard J E Skipworth; Grant D Stewart; Cornelis H C Dejong; Tom Preston; Kenneth C H Fearon Journal: Clin Nutr Date: 2007-05-15 Impact factor: 7.324
Authors: F Hong; T M Habermann; L I Gordon; H Hochster; R D Gascoyne; V A Morrison; R I Fisher; N L Bartlett; P J Stiff; B D Cheson; M Crump; S J Horning; B S Kahl Journal: Ann Oncol Date: 2014-03 Impact factor: 32.976
Authors: Vicki A Morrison; Linda McCall; Hyman B Muss; Aminah Jatoi; Harvey J Cohen; Constance T Cirrincione; Jennifer A Ligibel; Jacqueline M Lafky; Arti Hurria Journal: J Geriatr Oncol Date: 2017-12-08 Impact factor: 3.599
Authors: Philippe Atlan; Mohamed Amine Bayar; Emilie Lanoy; Benjamin Besse; David Planchard; Jordy Ramon; Bruno Raynard; Sami Antoun Journal: Support Care Cancer Date: 2017-06-08 Impact factor: 3.603
Authors: Suzanne E Dahlberg; Joan H Schiller; Philip B Bonomi; Alan B Sandler; Julie R Brahmer; Suresh S Ramalingam; David H Johnson Journal: J Thorac Oncol Date: 2013-09 Impact factor: 15.609
Authors: Jinlu Shan; Yanli Xiong; Dong Wang; Mingfang Xu; Y I Yang; Kan Gong; Zhenzhou Yang; G E Wang; Xueqin Yang Journal: Mol Clin Oncol Date: 2015-02-06
Authors: Sai Yendamuri; Joseph Barbi; Sarabjot Pabla; Cara Petrucci; Achamaporn Punnanitinont; Mary Nesline; Sean T Glenn; Paul Depietro; Antonios Papanicalou-Sengos; Carl Morrison; Grace K Dy; Peter L Elkin Journal: J Thorac Oncol Date: 2019-08-06 Impact factor: 15.609